Loading...

PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 108€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 227€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  2. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  3. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  4. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  5. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  6. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  7. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  8. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  9. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  10. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  11. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  12. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  13. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  14. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  15. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  16. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  17. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  18. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  19. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  20. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  21. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  22. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  23. Pinto NA, et al. 2023. Cell Death Differ. :. PubMed
  24. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  25. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  26. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  27. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  28. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  29. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  30. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  31. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  32. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  33. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  34. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  35. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  36. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  37. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  38. Cozzolino M, et al. 2023. Int J Mol Sci. 24:. PubMed
  39. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  40. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  41. Roy S, et al. 2023. J Clin Invest. 133:. PubMed
  42. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  43. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  44. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  45. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  46. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  47. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  48. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  49. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  50. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  51. Gawish R, et al. 2022. Elife. 11:. PubMed
  52. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  53. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  54. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  55. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  56. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  57. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  58. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  59. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  60. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  61. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  62. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  63. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  64. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  65. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  66. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  67. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  68. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  69. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  70. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  71. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  72. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  73. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  74. Sun P, et al. 2015. J Hepatol. . PubMed
  75. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  76. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  77. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  78. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  79. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  80. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  81. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  82. Morales D, et al. 2015. J Virol. 89:337. PubMed
  83. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  84. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  85. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  86. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  87. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  88. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  89. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  90. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  91. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  92. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  93. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  94. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  95. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  96. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  97. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  98. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  99. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  100. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  101. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  102. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  103. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  104. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  105. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  106. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  107. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  108. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  109. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  110. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  111. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  112. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  113. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  114. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  115. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  116. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  117. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  118. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  119. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  120. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  121. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  122. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  123. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  124. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  125. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  126. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  127. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  128. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  129. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  130. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  131. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  132. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  133. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  134. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  135. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  136. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  137. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  138. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  139. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  140. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  141. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  142. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  143. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  144. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  145. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  146. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  147. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  148. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  149. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  150. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  151. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  152. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  153. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  154. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  155. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  156. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  157. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  158. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  159. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  160. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  161. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  162. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  163. Kim M, et al. 2018. Immunity. 49:151. PubMed
  164. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  165. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  166. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  167. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  168. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  169. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  170. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  171. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  172. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  173. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  174. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  175. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  176. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  177. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  178. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  179. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  180. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  181. Issah Y, et al. 2021. Elife. 10:. PubMed
  182. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  183. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  184. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  185. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  186. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  187. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  188. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  189. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  190. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  191. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  192. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  193. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  194. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  195. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  196. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  197. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  198. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  199. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  200. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  201. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  202. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  203. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  204. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  205. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  206. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  207. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  208. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  209. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  210. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  211. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  212. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  213. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  214. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  215. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  216. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  217. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  218. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  219. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  220. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  221. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  222. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  223. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  224. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  225. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  226. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
  227. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  228. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  229. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  230. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  231. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
RRID
AB_1186099 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Spark Red™ 718 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Spark Blue™ 574 anti-mouse Ly-6G (Flexi-Fluor™) 1A8 FC
Go To Top Version: 3    Revision Date: 01.06.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account